Telomir Pharmaceuticals (Telomir Pharmaceuticals) Other Operating Expense : $2.14 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Other Operating Expense?

Telomir Pharmaceuticals's Other Operating Expense for the three months ended in Mar. 2024 was $0.37 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was $2.14 Mil.

Telomir Pharmaceuticals's quarterly Other Operating Expense declined from Sep. 2023 ($0.59 Mil) to Dec. 2023 ($0.48 Mil) and declined from Dec. 2023 ($0.48 Mil) to Mar. 2024 ($0.37 Mil).

Telomir Pharmaceuticals's annual Other Operating Expense increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) and increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($1.77 Mil).

Telomir Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Telomir Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Other Operating Expense Chart

Telomir Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Other Operating Expense

1.77

Telomir Pharmaceuticals Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial				-	0.70	0.59	0.48	0.37

Telomir Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.14 Mil.

Telomir Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Telomir Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024